Agent Operator
Agentic AI platform to automate life science workflows
Platform · Cloud SaaSCompany source
Company profile
About Grove AI
Grove AI is a clinical trial technology company that deploys agentic AI solutions to accelerate clinical research operations at scale. The company's flagship product, Grace, is an AI-powered Digital Staff agent that automates participant recruitment, prescreening, scheduling, and engagement across the clinical trial lifecycle. Grace operates 24/7 in multiple languages, responding to participant inquiries in under 30 seconds and seamlessly integrating with existing clinical trial management systems. The Grove AI PRM (Participant Relationship Management) platform unifies all participant interactions in a single intelligent system, enabling real-time optimization of recruitment workflows. Grove AI serves leading site networks, contract research organizations (CROs), and pharmaceutical sponsors conducting Phase I through Phase III clinical trials. The company's solutions have demonstrated significant impact, including a 2.7x increase in enrollment rates, 28% improvement in screening pass rates, and 580% increase in scheduled on-site visits. Grove AI has processed over 9.9 million participant queries, scheduled nearly 30,000 appointments, and saved over 56,500 hours in manual workflows. The company is backed by world-class investors and advised by former executives from Novartis, UCB, ICON, Google, and other leading healthcare and technology organizations. In January 2026, Grove AI was acquired by Hippocratic AI, marking a significant milestone in the company's growth trajectory.
Company description Grove AI official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Grove AI?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Alzheimer's disease
- kidney disease
- memory-related conditions
- vaccine trials
Who it serves
- Clinical Research Sites
- CROs
- Pharmaceutical Sponsors
- Site Networks/SMOs
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Advarra, Calendly, Clinical Conductor, CRIO, Facebook Ads, HubSpot, Microsoft Outlook, RealTime, Salesforce.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Acquired by Hippocratic AI (January 2026). Achieved ISO 42001 Certification (October 2025). Launched Agent Operator platform (October 2025). Named finalist for 2025 Pantheon Awards and Citeline Innovative Clinical Trial Solutions Award. Announced Clinical Research Site Advisory Council (August 2025). Unveiled PRM platform (May 2025). Grace received Generic IRB Approval (April 2025).
Partnerships
Recorded partners
- Celerion
- IMA Clinical Research
- K2 Medical Research
- The Cognitive and Research Center of New Jersey
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Grace (Digital Staff Agent)
AI agent for clinical trial participant recruitment and engagement available 24/7
Software · Cloud SaaSCompany source
Grove AI PRM (Participant Relationship Management)
AI-powered participant relationship management platform for clinical trials
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
2.7x increase in enrollment rates
Pivotal Phase 3 trial with 144 participants randomized
28% increase in screening pass rate
Phase I kidney disease trial at Celerion
580% increase in scheduled on-site visits
Leading site network across 15+ sites
40.5% prescreen visit completion rate
K2 Medical Research for 50+ demographic
66% screening qualification rate
K2 Medical Research memory-related conditions
60% faster recruitment processes
General platform performance
Under 30 second response time
24/7 participant inquiry responses
9,999,906+ queries supported
Total platform usage
29,900+ appointments scheduled
Total platform usage
56,500+ hours saved
Manual workflow automation
Celerion
Increased screening pass rates and recruitment efficiency for kidney disease Phase I trial
28% increase in screening pass rates, $20,000+ saved in 2 days, contacted 250 participants in English and Spanish, scheduled 40 participants in 2 days, prescreened 39,000+ participants
IMA Clinical Research
Accelerated prescreening and participant triage
Triaged over 1,500 participants in 30 days, accelerated timelines, reduced costs, averted staff burnout
K2 Medical Research
Accelerated recruitment for Alzheimer's and vaccine trials for participants aged 50+
40.5% prescreen visit completion rate, 66% screening qualification rate, prescreened and booked hundreds of participants in 2 months, freed staff of thousands of hours
Leading Site Network (US-based)
Prescreening and scheduling participant leads across 15+ sites
580% increase in scheduled on-site visits, 24% increase in first call pickup rate, 56% showed up for on-site visit
Pivotal Phase 3 Trial (12 trials)
Accelerated enrollment for Phase 3 trials
2.7x increase in enrollment rates, 144 participants randomized, 340,000+ automated personalized interactions
The Cognitive and Research Center of New Jersey
Doubled participant screenings with multilingual support
Doubled participant screenings in 30 days, Grace performs work of 4 staff members, supports multiple languages for diverse populations
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Grove AI
Recent articles published on Grove AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.